Ligand Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Ligand Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ligand Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ligand Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ligand Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 01 Dec 2023 | Palvella Therapeutics Enters into Co-Development Agreement with Ligand Pharma | Partnership | - |
Palvella Therapeutics LLC
Ligand Pharmaceuticals Inc |
| 01 Nov 2023 | Ligand Pharmaceuticals Acquires Tolerance Therapeutics for USD20 Million | Acquisition |
Ligand Pharmaceuticals Inc
|
Tolerance Therapeutics Inc
|
| 18 Oct 2023 | Ligand Pharma Acquires Soticlestat Royalties from Ovid Therapeutics for USD30 Million | Asset Transaction |
Ligand Pharmaceuticals Inc
|
Ovid Therapeutics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer